BRIEF RESEARCH REPORT
Published on 22 Jan 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
doi 10.3389/fimmu.2025.1514033
- 1,388 views
- 2 citations